WallStreetZenWallStreetZen

NASDAQ: IMNN
Imunon Inc Stock

$1.28+0.13 (+11.3%)
Updated Jun 11, 2024
IMNN Price
$1.28
Fair Value Price
$0.47
Market Cap
$12.03M
52 Week Low
$0.48
52 Week High
$2.00
P/E
-0.63x
P/B
1.42x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$18.85M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.69
Operating Cash Flow
-$21M
Beta
0.66
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

IMNN Overview

Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how IMNN scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

IMNN ($1.28) is overvalued by 174.76% relative to our estimate of its Fair Value price of $0.47 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
IMNN ($1.28) is not significantly undervalued (174.76%) relative to our estimate of its Fair Value price of $0.47 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
IMNN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more IMNN due diligence checks available for Premium users.

Be the first to know about important IMNN news, forecast changes, insider trades & much more!

Valuation

IMNN fair value

Fair Value of IMNN stock based on Discounted Cash Flow (DCF)
Price
$1.28
Fair Value
$0.47
Overvalued by
174.76%
IMNN ($1.28) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
IMNN ($1.28) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
IMNN is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

IMNN price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.63x
Industry
-3.83x
Market
29.53x

IMNN price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.42x
Industry
6.25x
IMNN is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

IMNN's financial health

Profit margin

Revenue
$0.0
Net Income
-$4.9M
Profit Margin
0%
IMNN's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$14.3M
Liabilities
$5.8M
Debt to equity
0.69
IMNN's short-term assets ($12.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
IMNN's short-term assets ($12.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
IMNN's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
IMNN's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.9M
Investing
$2.4M
Financing
$0.0
IMNN's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

IMNN vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
IMNN$12.03M+11.30%-0.63x1.42x
EVAX$12.17M-3.31%-0.40x-2.57x
ELAB$11.73M-0.32%-1.68x4.72x
PSTV$12.38M-1.81%-0.71x-2.56x
VCNX$11.44M+3.14%-0.27x4.31x

Imunon Stock FAQ

What is Imunon's quote symbol?

(NASDAQ: IMNN) Imunon trades on the NASDAQ under the ticker symbol IMNN. Imunon stock quotes can also be displayed as NASDAQ: IMNN.

If you're new to stock investing, here's how to buy Imunon stock.

What is the 52 week high and low for Imunon (NASDAQ: IMNN)?

(NASDAQ: IMNN) Imunon's 52-week high was $2.00, and its 52-week low was $0.48. It is currently -36% from its 52-week high and 166.67% from its 52-week low.

How much is Imunon stock worth today?

(NASDAQ: IMNN) Imunon currently has 9,400,889 outstanding shares. With Imunon stock trading at $1.28 per share, the total value of Imunon stock (market capitalization) is $12.03M.

Imunon stock was originally listed at a price of $12,899.25 in Mar 1, 1999. If you had invested in Imunon stock at $12,899.25, your return over the last 25 years would have been -99.99%, for an annualized return of -30.84% (not including any dividends or dividend reinvestments).

How much is Imunon's stock price per share?

(NASDAQ: IMNN) Imunon stock price per share is $1.28 today (as of Jun 11, 2024).

What is Imunon's Market Cap?

(NASDAQ: IMNN) Imunon's market cap is $12.03M, as of Jun 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Imunon's market cap is calculated by multiplying IMNN's current stock price of $1.28 by IMNN's total outstanding shares of 9,400,889.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.